Browsing Tag

Baudax

Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of…

Jason Junior Apr 25, 2023

…

Health

Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000

Jason Junior Jan 24, 2023

MALVERN, Pa., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on innovative products for hospital and related settings, today announced the successful outcome of its first interim…

Health

Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders…

Jason Junior Jul 1, 2021

MALVERN, Pa., July 01, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that Glass Lewis & Co., a…